The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Self-Administered Medication-Global Market Insights and Sales Trends 2024
Synopsis
Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient.
The global Self-Administered Medication market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Self-Administered Medication in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Self-Administered Medication market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous segment is estimated at % CAGR for the next seven-year period.
By distribution channel, the hospital pharmacies segment is expected to represent significant revenue growth by the end of 2025. However, the online pharmacies distribution channel segment is expected to register a healthy CAGR during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Self-Administered Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Self-Administered Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Self-Administered Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Self-Administered Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Self-Administered Medication covered in this report include Pfizer, Abbott Laboratories, Novartis, Sanofi, BD, Takeda Pharmaceutical, Mylan, Amgen and Antares Pharma, etc.
The global Self-Administered Medication market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Abbott Laboratories
Novartis
Sanofi
BD
Takeda Pharmaceutical
Mylan
Amgen
Antares Pharma
Purdue Pharma
Global Self-Administered Medication market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Self-Administered Medication market, Segment by Type:
Oral
Subcutaneous
Nasal
Transdermal
Others
Global Self-Administered Medication market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Self-Administered Medication companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Self-administration is, in its medical sense, the process of a subject administering a pharmacological substance to themself. A clinical example of this is the subcutaneous "self-injection" of insulin by a diabetic patient.
The global Self-Administered Medication market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Self-Administered Medication in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Self-Administered Medication market. Oral, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Subcutaneous segment is estimated at % CAGR for the next seven-year period.
By distribution channel, the hospital pharmacies segment is expected to represent significant revenue growth by the end of 2025. However, the online pharmacies distribution channel segment is expected to register a healthy CAGR during the forecast period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Self-Administered Medication, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Self-Administered Medication market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Self-Administered Medication market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Self-Administered Medication sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Self-Administered Medication covered in this report include Pfizer, Abbott Laboratories, Novartis, Sanofi, BD, Takeda Pharmaceutical, Mylan, Amgen and Antares Pharma, etc.
The global Self-Administered Medication market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Abbott Laboratories
Novartis
Sanofi
BD
Takeda Pharmaceutical
Mylan
Amgen
Antares Pharma
Purdue Pharma
Global Self-Administered Medication market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Self-Administered Medication market, Segment by Type:
Oral
Subcutaneous
Nasal
Transdermal
Others
Global Self-Administered Medication market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Self-Administered Medication companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Self-Administered Medication
1.1 Self-Administered Medication Market Overview
1.1.1 Self-Administered Medication Product Scope
1.1.2 Self-Administered Medication Market Status and Outlook
1.2 Global Self-Administered Medication Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Self-Administered Medication Market Size by Region (2018-2029)
1.4 Global Self-Administered Medication Historic Market Size by Region (2018-2023)
1.5 Global Self-Administered Medication Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Self-Administered Medication Market Size (2018-2029)
1.6.1 North America Self-Administered Medication Market Size (2018-2029)
1.6.2 Europe Self-Administered Medication Market Size (2018-2029)
1.6.3 Asia-Pacific Self-Administered Medication Market Size (2018-2029)
1.6.4 Latin America Self-Administered Medication Market Size (2018-2029)
1.6.5 Middle East & Africa Self-Administered Medication Market Size (2018-2029)
2 Self-Administered Medication Market by Type
2.1 Introduction
2.1.1 Oral
2.1.2 Subcutaneous
2.1.3 Nasal
2.1.4 Transdermal
2.1.5 Others
2.2 Global Self-Administered Medication Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Self-Administered Medication Historic Market Size by Type (2018-2023)
2.2.2 Global Self-Administered Medication Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Self-Administered Medication Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Self-Administered Medication Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Self-Administered Medication Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Self-Administered Medication Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Self-Administered Medication Revenue Breakdown by Type (2018-2029)
3 Self-Administered Medication Market Overview by Application
3.1 Introduction
3.1.1 Hospital Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Online Pharmacies
3.2 Global Self-Administered Medication Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Self-Administered Medication Historic Market Size by Application (2018-2023)
3.2.2 Global Self-Administered Medication Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Self-Administered Medication Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Self-Administered Medication Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Self-Administered Medication Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Self-Administered Medication Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Self-Administered Medication Revenue Breakdown by Application (2018-2029)
4 Self-Administered Medication Competition Analysis by Players
4.1 Global Self-Administered Medication Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Self-Administered Medication as of 2022)
4.3 Date of Key Players Enter into Self-Administered Medication Market
4.4 Global Top Players Self-Administered Medication Headquarters and Area Served
4.5 Key Players Self-Administered Medication Product Solution and Service
4.6 Competitive Status
4.6.1 Self-Administered Medication Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Self-Administered Medication Products, Services and Solutions
5.1.4 Pfizer Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Abbott Laboratories
5.2.1 Abbott Laboratories Profile
5.2.2 Abbott Laboratories Main Business
5.2.3 Abbott Laboratories Self-Administered Medication Products, Services and Solutions
5.2.4 Abbott Laboratories Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Laboratories Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Self-Administered Medication Products, Services and Solutions
5.3.4 Novartis Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Self-Administered Medication Products, Services and Solutions
5.4.4 Sanofi Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 BD
5.5.1 BD Profile
5.5.2 BD Main Business
5.5.3 BD Self-Administered Medication Products, Services and Solutions
5.5.4 BD Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.5.5 BD Recent Developments
5.6 Takeda Pharmaceutical
5.6.1 Takeda Pharmaceutical Profile
5.6.2 Takeda Pharmaceutical Main Business
5.6.3 Takeda Pharmaceutical Self-Administered Medication Products, Services and Solutions
5.6.4 Takeda Pharmaceutical Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.6.5 Takeda Pharmaceutical Recent Developments
5.7 Mylan
5.7.1 Mylan Profile
5.7.2 Mylan Main Business
5.7.3 Mylan Self-Administered Medication Products, Services and Solutions
5.7.4 Mylan Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.7.5 Mylan Recent Developments
5.8 Amgen
5.8.1 Amgen Profile
5.8.2 Amgen Main Business
5.8.3 Amgen Self-Administered Medication Products, Services and Solutions
5.8.4 Amgen Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.8.5 Amgen Recent Developments
5.9 Antares Pharma
5.9.1 Antares Pharma Profile
5.9.2 Antares Pharma Main Business
5.9.3 Antares Pharma Self-Administered Medication Products, Services and Solutions
5.9.4 Antares Pharma Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.9.5 Antares Pharma Recent Developments
5.10 Purdue Pharma
5.10.1 Purdue Pharma Profile
5.10.2 Purdue Pharma Main Business
5.10.3 Purdue Pharma Self-Administered Medication Products, Services and Solutions
5.10.4 Purdue Pharma Self-Administered Medication Revenue (US$ Million) & (2018-2023)
5.10.5 Purdue Pharma Recent Developments
6 North America
6.1 North America Self-Administered Medication Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Self-Administered Medication Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Self-Administered Medication Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Self-Administered Medication Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Self-Administered Medication Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Self-Administered Medication Market Dynamics
11.1 Self-Administered Medication Industry Trends
11.2 Self-Administered Medication Market Drivers
11.3 Self-Administered Medication Market Challenges
11.4 Self-Administered Medication Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
